A recent meta-analysis presented at EuroPCR 2026 evaluates long-term outcomes for patients with left main coronary artery disease, focusing on two revascularization strategies: percutaneous coronary intervention (PCI) using drug-eluting stents (DES) and coronary artery bypass grafting (CABG). The analysis, which included data from 4,394 patients across four significant trials—SYNTAX, PRECOMBAT, NOBLE, and EXCEL—found that the rates of all-cause mortality after 10 years were 23.5% for DES PCI and 23.1% for CABG, indicating no statistically significant difference between the two methods. Furthermore, the study revealed consistent mortality rates across various clinical subgroups and follow-up periods, reinforcing the notion that both treatment strategies are viable options for patients deemed suitable for revascularization. The findings highlight the importance of a multidisciplinary team approach in clinical decision-making, suggesting that either DES PCI or CABG may be appropriate based on individual patient assessments. This research strengthens the role of DES PCI in contemporary practice, providing valuable insights for healthcare professionals.